%20(1).png)
Decoded is the podcast hosted by Dr. Jurgi Camblong - Founder and CEO of SOPHiA GENETICS, molecular biologist, and global leader and pioneer of data-driven medicine.
In each episode, he connects with world-class scientists, clinicians, innovators, and policymakers to uncover how data, technology, and clinical expertise converge to transform care.
From accelerating cancer diagnostics to transforming the understanding of rare and inherited disorders, Decoded goes beyond the buzz to reveal how innovation translates into real outcomes for patients worldwide.
With a sharp focus on multimodal data, AI in healthcare, and global equal access to patient care, Decoded goes beyond theory to decode what’s working - and what it takes to scale innovation that truly improves lives.
Dr. Jurgi Camblong
Co-founder and CEO, SOPHiA GENETICS
A visionary entrepreneur and molecular biologist, Dr. Camblong is leading the global shift toward data-driven medicine. With a PhD in Life Sciences from the University of Geneva, an EMBA from EPFL/HEC Lausanne, and publications in Cell, Science, and Nature, he drives innovation that empowers clinicians to improve outcomes worldwide, for millions of patients.
Raluca Baciu
Marketing & Communications Manager
As the show’s executive producer, she spearheaded its launch in June 2025 and drove its rapid expansion, building a global community of over 10,000 subscribers and surpassing 21,000 listening hours in less than a year. Expert in digital storytelling for AI and biotech, Raluca orchestrates the podcast’s vision and production, amplifying high-impact conversations with world-leading scientists and iconic tech founders.
Dr. David Rhew
Global Chief Medical Officer, Microsoft
From advancing responsible AI through the Trustworthy & Responsible AI Network to pioneering multimodal diagnostics like oculomics, Dr. Rhew is shaping how population-scale data and technology transform care. At Microsoft and beyond, his work spans clinical strategy, policy, and real-world deployment—bringing vision, credibility, and action to some of healthcare’s most complex challenges.
Professor Mayana Zatz
Professor of Human and Medical Genetics, University of São Paulo (USP), Brazil
Professor Mayana Zatz is one of the world’s pioneers of human genetics, rare diseases, and aging. Across her career, she has personally supported more than 16,000 families affected by rare genetic disorders and has conducted genomic research on more than 100,000 families to uncover the genetic foundations of resilience, aging, and longevity. Her work has shaped modern genetics and continues to influence global approaches to gene therapy and prevention.
.png)
Dr. Michael Snyder
Chair of Genetics at Stanford Medicine and Director of the Center for Genomics and Personalized Medicine
A pioneer in the field of systems biology, he is one of the most cited scientists in the world, known for his groundbreaking work in using big data and wearables to revolutionize precision health.
.png)
Professor Nicholas Proudfoot
Professor of Molecular Biology, University of Oxford
Nick is a pioneer in molecular biology whose discoveries revealed how genes are switched on and off. His five decades of research at the Sir William Dunn School of Pathology at Oxford University have shaped modern molecular biology and inspired generations of scientists.
Parminder Bhatia
Chief AI Officer, GE Healthcare
Parry leads strategy and deployment of AI across imaging, diagnostics, and care pathways. His work focuses on clinically validated, workflow-embedded AI that improves access, speed, and outcomes at scale.
.png)
Dr. Pedram Razavi
Director, Liquid Biopsy and Cancer Genomics, Memorial Sloan Kettering Cancer
Dr. Razavi bridges research and practice at Memorial Sloan Kettering Cancer Center, driving innovation in genomics and liquid biopsy. His work translates complex molecular insights into actionable care—offering new options to people facing cancer.
.png)
Professor Umberto Malapelle
Associate Professor, Department of Public Health, University Federico II of Naples President, International Society for Liquid Biopsy
A global authority in molecular pathology, Professor Malapelle has helped define the standard for precision diagnostics in oncology. Through his work, he continues to bridge research and clinical practice, driving new models of care and access.